Influence of chest gamma-irradiation on cough response in awake guinea pigs.

J Physiol Pharmacol

Institute of Pathological Physiology, Jessenius Faculty of Medicine, Comenius University, and Centre of Oncology-Department of Radiotherapy and Oncology, Martin Teaching Hospital, Slovakia.

Published: November 2007

Radiotherapy of tumors in the chest and neck regions may have serious pulmonary side effects. It is well known that inflammation is an essential manifestation of radiation-induced injury. This can heal spontaneously, by specific treatment, or it may progress to more intensive inflammation up to irreversible pulmonary fibrosis. To prevent such complications, it would be useful to have a simple non-invasive and sensitive method for monitoring the course of airway and lung post-irradiation inflammation. This study is devoted to search for such a method. We supposed that cough response intensity (CRI) could be one of the methods, which we are looking for. Guinea pigs (Trik strain, n=32) were used in the study. Animals were divided into two subgroups. Animals of a non-untreated (NT) group (n=14; M=7, F=7) were submitted to sham chest irradiation. The animals of a treated (XRT) group (n=18; M=9, F=9) were exposed to a single dose of gamma rays. Cough was provoked by exposure of animals to citric acid aerosol (CA) in gradually increasing concentrations (0.05-1.6M). CRI testing was performed two days before sham/real chest irradiation, than on 1st, 3rd, 10th, 15th, 21st, and 28th days following the day of irradiation. CRI was quantified in each animal by counting the number of coughs induced by all used concentration of CA. We found a significant increase of CRI in the animals of XRT group on 10th and 21st day compared with the NT animals. An increase of CRI also was found inside the XRT group on the 10th day after irradiation compared with the pre-irradiation value of CRI.

Download full-text PDF

Source

Publication Analysis

Top Keywords

xrt group
12
cough response
8
guinea pigs
8
chest irradiation
8
day irradiation
8
increase cri
8
group 10th
8
cri
6
animals
6
influence chest
4

Similar Publications

Background: Proton therapy (PRT) is an innovative radiotherapeutic modality for the treatment of cancer with unique ballistic properties. The depth-dose distribution of a proton beam reduces exposure of healthy tissues to radiations, compared with photon-therapy (XRT). To date, only few indications for proton-therapy, like pediatric cancers, chordomas, or intra-ocular neoplasms, are reimbursed by Health systems.

View Article and Find Full Text PDF

Objectives: To determine the effect of external beam radiation (XRT) on preventing severe heterotopic ossification (HO) after acetabular surgery.

Methods: Design: Randomized controlled trial.

Setting: Two level I academic trauma centers.

View Article and Find Full Text PDF

Background: Nipple delay (ND) is a staged procedure that improves nipple-areolar complex (NAC) viability in nipple-sparing mastectomy (NSM) patients who are high-risk for NAC or skin-flap necrosis. This study compared postoperative outcomes and risk factors between patients treated with ND-NSM and NSM alone.

Methods: Patient demographics, risk factors for NAC or skin-flap necrosis, tumor characteristics, and operative outcomes were compared between ND-NSM and NSM groups from 2009 to 2023.

View Article and Find Full Text PDF
Article Synopsis
  • Radiation therapy (RT) for glioma can lead to neurotoxicity, and this study compares the effects of proton RT (PRT) versus photon RT (XRT) on brain imaging metrics in patients.
  • In a study of 34 patients with WHO grade 2-3 gliomas, significant ventricular volume increases were noted in both RT groups, with XRT showing greater brain volume loss (26.55%) compared to PRT (12.03%) after two years.
  • While PRT patients did not show overall cognitive decline, individual cognitive performance correlated with brain volume loss, indicating the need for further research on long-term cognitive effects following radiation treatment.
View Article and Find Full Text PDF

Background: Combining interleukin-2 (IL-2) with radiotherapy (RT) and immune checkpoint blockade (ICB) has emerged as a promising approach to address ICB resistance. However, conventional IL-2 cytokine therapy faces constraints owing to its brief half-life and adverse effects. RDB 1462, the mouse ortholog of Nemvaleukin alfa, is an engineered IL-2 with an intermediate affinity that selectively stimulates antitumor CD8 T and NK cells while limiting regulatory T cell expansion.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!